One-time cell therapy offers long-term survival hope for patients with advanced melanoma
A one-time immunotherapy treatment using a patient’s own immune cells has shown long-lasting benefit for people with advanced melanoma, a serious form of skin cancer, according to new five-year follow-up […]
Immunotherapy gives head and neck cancer patients extra years disease-free
An immunotherapy helps patients live years longer without their cancer getting worse or coming back, a major phase III trial has found. Pembrolizumab kept cancer at bay for some patients […]
Groundbreaking discovery could revolutionise treatment for one of the deadliest cancers
A new study, co-led by Leukaemia UK and Wellcome funded researcher Dr Konstantinos Tzelepis at the Cambridge Stem Cell Institute, has uncovered a groundbreaking finding that could transform treatment for […]
Dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or microsatellite instability high unresectable or metastatic colorectal cancer now available in the UK
Opdivo® (nivolumab) in combination with Yervoy® (ipilimumab) has been granted an indication extension in the UK by the MHRA1,2 and is recommended by NICE for use on the NHS in […]
Immunotherapy gives head and neck cancer patients extra years disease free
An immunotherapy treatment helps patients live years longer without their cancer getting worse or coming back, a major phase III trial has found. Pembrolizumab kept cancer at bay for some […]
Oncology/Haematology Immunotherapy Study Day
Join our team of expert 10 professionals, for this introductory immunotherapy study day. Delegates will gain knowledge of the mode of action of immune checkpoint inhibitors, early identification and management […]
New imaging technique could spot patients with aggressive brain tumours who would benefit from immunotherapy
A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, according to researchers. A team from The Institute of Cancer Research, London, has […]
The Royal Marsden and Francis Crick Institute launches UK-wide programme into cancer immunotherapy response
A new programme has been launched, led by The Royal Marsden and the Francis Crick Institute, to better understand immunotherapy response and side effects in cancer. Funded through a £9 […]
Checkmate studies highlight the benefits of immunotherapies nivolumab and ipilimumab for different patients with melanoma
Two studies were presented at the American Society of Clinical Oncology (ASCO) annual meeting by Professor James Larkin, Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, and colleagues. […]
Scientists uncover protein with the power to help or hinder breast cancer progression
New research has shed light on how one of the most difficult-to-treat types of breast cancer defends itself against immune attack. The findings could help more patients to benefit from […]
